Health & Medicine Potential of phase II clinical trials in drug development

1. POTENTIAL OF PHASE II TRIALS IN DRUG DEVELOPMENT Dr. Bhaswat S. Chakraborty Senior Vice President and Chairman, R&D Core Committee Cadila Pharmaceuticals Ltd. 5th…

Documents Adaptive Designs for Clinical Trials Frank Bretz Novartis 24 April 2013, Tel Aviv.

Slide 1 Adaptive Designs for Clinical Trials Frank Bretz Novartis 24 April 2013, Tel Aviv Slide 2 What are Adaptive Designs? 2 Slide 3 Three definitions of adaptive designs…

Documents Safer Wards, Safe Hospitals Technology Fund A successful bid approach 

PowerPoint Presentation Safer Wards, Safe Hospitals Technology Fund A successful bid approach  Christine Walters Director of IM&T, The Pennine Acute Hospitals NHS…

Documents Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill...

Slide 1Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill Mietlowski, Biometrics and Data Management, Novartis Oncology KOL Adaptive…